Welcome to the New Mexico Chapter of the American College of Cardiology
ACC Live Courses For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings |
Please join your cardiology colleagues at the ACC Rockies Chapter Meeting in Park City, Utah for updates on ACC affairs, the potential new CV Board, and clinical topics such as Genetic and Sports EP, plus a discussion on the growing role of obesity medications in heart failure, and the first-ever Cardiology State-of-the-State report. There will be many opportunities for networking, as well!.
For more information and to register, please visit: 
Latest in Cardiology from ACC.org
- Federal Government Shuts Down as Telehealth Flexibilities LapseThe federal government shut down on Oct. 1 as lawmakers failed to reach a funding agreement. According to contingency plans from the Centers for Medicare and Medicaid Services (CMS), operations such as claims processing for Medicare, Medicaid and the Children's Health Insurance Program will continue.
- Eagle’s Eye View: Oral Semaglutide for Weight Loss; Anticoagulants for PAH; The ECDP on TR Evaluation and ManagementIn this week’s View, Dr. Eagle looks at the value of oral semaglutide for weight loss. He then explores whether anticoagulants improve survival in patients with pulmonary arterial hypertension (PAH).
- Nicole Bhave, MD, FACC, Named ACC Annual Scientific Session Vice ChairThe ACC has named Nicole Martin Bhave, MD, FACC, as the next Annual Scientific Session vice chair for ACC.27 and ACC.28. Her term will be followed by a two-year term as chair for ACC.29 and ACC.30.
- Nearly Everyone Has One or More CV Risk Factors Before a CVD EventAlmost all individuals (99%) who experienced a cardiovascular disease event were exposed to one or more nonoptimal traditional risk factor, challenging the belief that cardiovascular disease often strikes people without warning, according to a large study published Sept. 29 in JACC.
- Editors' Corner | Making AI An Ally in CV CareArtificial Intelligence (AI) has become commonplace, affecting most facets of daily life, and the field of medicine is no exception. Now the question is how do we harness these new and emerging tools and make them an ally in cardiovascular care?